Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
20-Apr-2026 | 545.75 | 546.9 | 531.25 | 533.3 | 4,939 | 5,59,40,697.6 | 56,555 |
21-Apr-2026 | 533.3 | 539.5 | 532.05 | 534.3 | 6,320 | 4,17,22,701.1 | 43,238 |
22-Apr-2026 | 528.9 | 538.5 | 526.05 | 528.75 | 6,161 | 5,68,97,586.45 | 57,266 |
23-Apr-2026 | 526 | 547.45 | 526 | 539.5 | 6,720 | 9,36,21,944.85 | 88,009 |
24-Apr-2026 | 544.2 | 546.9 | 512.1 | 514.3 | 10,164 | 10,49,01,501.95 | 1,09,935 |
27-Apr-2026 | 525.9 | 532.7 | 513.9 | 531.3 | 7,173 | 8,29,43,265.6 | 82,050 |
28-Apr-2026 | 530 | 539.8 | 529.95 | 533.2 | 3,725 | 4,50,12,055.1 | 50,941 |
29-Apr-2026 | 531 | 550 | 527.85 | 543.7 | 8,436 | 8,45,85,885.95 | 97,334 |
30-Apr-2026 | 542.1 | 549.95 | 536.65 | 547.3 | 11,425 | 13,67,04,810.6 | 1,54,382 |
04-May-2026 | 550 | 563.85 | 544.6 | 559.15 | 17,722 | 19,48,48,948.2 | 1,81,544 |
05-May-2026 | 560 | 562.1 | 550 | 552.8 | 6,468 | 4,94,73,508.3 | 50,780 |
06-May-2026 | 553.6 | 560.4 | 550.15 | 552.15 | 7,285 | 6,65,08,853.15 | 62,685 |
07-May-2026 | 555.9 | 560 | 545 | 548 | 6,073 | 5,94,72,376.65 | 66,561 |
08-May-2026 | 546.8 | 561 | 546.8 | 557.1 | 7,153 | 8,98,20,854.2 | 92,612 |
11-May-2026 | 557.95 | 567 | 535.1 | 538.75 | 10,158 | 13,97,67,529.05 | 1,36,438 |
12-May-2026 | 543.05 | 548.6 | 523.5 | 528.4 | 18,933 | 22,26,79,617.45 | 2,36,492 |
13-May-2026 | 528.4 | 550 | 528.4 | 540.35 | 8,609 | 8,13,58,779.05 | 88,199 |
14-May-2026 | 545.9 | 557 | 512.65 | 527.9 | 38,519 | 54,36,76,272.3 | 3,91,620 |
15-May-2026 | 531.7 | 532.3 | 500.05 | 516.95 | 20,286 | 20,06,32,582.8 | 1,91,890 |
18-May-2026 | 512.45 | 533.1 | 505.55 | 519.75 | 21,405 | 31,61,73,290.3 | 4,33,337 |
19-May-2026 | 519.75 | 530.9 | 517.95 | 519.8 | 14,592 | 15,79,44,764.6 | 1,93,763 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
